| Peter Gottlieb, MD | |
|
12605 E 16th Ave, Aurora, CO 80045-2545 | |
| (303) 493-7000 | |
| (303) 724-6779 |
| Full Name | Peter Gottlieb |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 40 Years |
| Location | 12605 E 16th Ave, Aurora, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174537492 | NPI | - | NPPES |
| 01341270 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 34127 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Colorado Hospital Authority | Aurora, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Physicians Incorporated | 3476465667 | 2657 |
News Archive
Scientists from the University of Alberta have published findings that the antiviral drug remdesivir prevents replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by inhibiting RNA replication. The study, published in April 2020 in the Journal of Biological Chemistry, follows on the heels of earlier reports from the same lab in February, showing the drug's effectiveness against the related Middle East Respiratory Syndrome (MERS) virus.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today that it consummated its previously announced private placement to sell approximately $15.2 million of its units to several institutional investors, including the Special Situations Funds, for net proceeds of approximately $14.1 million after the deduction of offering expenses.
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
The Johns Hopkins University School of Medicine will hold its 21st annual Mood Disorders Symposium titled Bipolar Revisited: Where We've Been, Where We're Going, at the Johns Hopkins School of Medicine, April 24, to draw attention to new findings in basic and clinical research on depression and bipolar disorder.
The Roger C. Lipitz Center for Integrated Health Care at the Johns Hopkins Bloomberg School of Public Health has received a $1.7 million grant from the John A. Hartford Foundation to help primary care practices improve the quality and outcomes of health care for older adults with chronic illnesses.
› Verified 8 days ago
| Entity Name | University Physicians Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962461889 PECOS PAC ID: 3476465667 Enrollment ID: O20031105000375 |
News Archive
Scientists from the University of Alberta have published findings that the antiviral drug remdesivir prevents replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by inhibiting RNA replication. The study, published in April 2020 in the Journal of Biological Chemistry, follows on the heels of earlier reports from the same lab in February, showing the drug's effectiveness against the related Middle East Respiratory Syndrome (MERS) virus.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today that it consummated its previously announced private placement to sell approximately $15.2 million of its units to several institutional investors, including the Special Situations Funds, for net proceeds of approximately $14.1 million after the deduction of offering expenses.
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
The Johns Hopkins University School of Medicine will hold its 21st annual Mood Disorders Symposium titled Bipolar Revisited: Where We've Been, Where We're Going, at the Johns Hopkins School of Medicine, April 24, to draw attention to new findings in basic and clinical research on depression and bipolar disorder.
The Roger C. Lipitz Center for Integrated Health Care at the Johns Hopkins Bloomberg School of Public Health has received a $1.7 million grant from the John A. Hartford Foundation to help primary care practices improve the quality and outcomes of health care for older adults with chronic illnesses.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter Gottlieb, MD Po Box 110429, Aurora, CO 80042-0429 Ph: (303) 493-7000 | Peter Gottlieb, MD 12605 E 16th Ave, Aurora, CO 80045-2545 Ph: (303) 493-7000 |
News Archive
Scientists from the University of Alberta have published findings that the antiviral drug remdesivir prevents replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by inhibiting RNA replication. The study, published in April 2020 in the Journal of Biological Chemistry, follows on the heels of earlier reports from the same lab in February, showing the drug's effectiveness against the related Middle East Respiratory Syndrome (MERS) virus.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today that it consummated its previously announced private placement to sell approximately $15.2 million of its units to several institutional investors, including the Special Situations Funds, for net proceeds of approximately $14.1 million after the deduction of offering expenses.
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
The Johns Hopkins University School of Medicine will hold its 21st annual Mood Disorders Symposium titled Bipolar Revisited: Where We've Been, Where We're Going, at the Johns Hopkins School of Medicine, April 24, to draw attention to new findings in basic and clinical research on depression and bipolar disorder.
The Roger C. Lipitz Center for Integrated Health Care at the Johns Hopkins Bloomberg School of Public Health has received a $1.7 million grant from the John A. Hartford Foundation to help primary care practices improve the quality and outcomes of health care for older adults with chronic illnesses.
› Verified 8 days ago
Samiran Bhattacharya, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1635 Aurora Ct, Aurora, CO 80045 Phone: 720-848-0000 | |
Payal Rohit Patel, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 303-724-6024 | |
Jonathan A Gutman, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Jeffrey Glasheen, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Micol Rothman, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Larry Allen, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Virginia Borges, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |